As of 2025-11-07, the Relative Valuation of Arcutis Biotherapeutics Inc (ARQT) is (24.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.10 USD, the upside of Arcutis Biotherapeutics Inc based on Relative Valuation is -196.1%.
The range of the Relative Valuation is (23.04) - (25.20) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.5x - 25.7x | 24.6x |
| Forward P/E multiples | 23.5x - 25.7x | 24.6x |
| Fair Price | (23.04) - (25.20) | (24.12) |
| Upside | -191.8% - -200.4% | -196.1% |
| Date | P/E |
| 2025-11-05 | -24.78 |
| 2025-11-04 | -24.49 |
| 2025-11-03 | -25.25 |
| 2025-10-31 | -25.81 |
| 2025-10-30 | -25.42 |
| 2025-10-29 | -25.79 |
| 2025-10-28 | -25.45 |
| 2025-10-27 | -20.03 |
| 2025-10-24 | -20.51 |
| 2025-10-23 | -20.48 |
| 2025-10-22 | -20.20 |
| 2025-10-21 | -21.05 |
| 2025-10-20 | -21.30 |
| 2025-10-17 | -21.30 |
| 2025-10-16 | -21.33 |
| 2025-10-15 | -22.06 |
| 2025-10-14 | -20.84 |
| 2025-10-13 | -21.13 |
| 2025-10-10 | -20.45 |
| 2025-10-09 | -21.12 |
| 2025-10-08 | -21.66 |
| 2025-10-07 | -20.98 |
| 2025-10-06 | -20.15 |
| 2025-10-03 | -20.32 |
| 2025-10-02 | -21.67 |
| 2025-10-01 | -20.15 |
| 2025-09-30 | -19.23 |
| 2025-09-29 | -18.99 |
| 2025-09-26 | -17.92 |
| 2025-09-25 | -17.06 |
| 2025-09-24 | -17.64 |
| 2025-09-23 | -17.95 |
| 2025-09-22 | -17.72 |
| 2025-09-19 | -17.73 |
| 2025-09-18 | -18.06 |
| 2025-09-17 | -17.48 |
| 2025-09-16 | -17.31 |
| 2025-09-15 | -17.27 |
| 2025-09-12 | -17.63 |
| 2025-09-11 | -18.04 |
| 2025-09-10 | -17.92 |
| 2025-09-09 | -18.29 |
| 2025-09-08 | -17.68 |
| 2025-09-05 | -17.49 |
| 2025-09-04 | -16.53 |
| 2025-09-03 | -16.26 |
| 2025-09-02 | -15.63 |
| 2025-08-29 | -15.83 |
| 2025-08-28 | -15.80 |
| 2025-08-27 | -15.96 |